Close Menu

An epigenomic analysis of neurons from Parkinson's disease patients reveals that the loss of TET2, a master regulator of cytosine modification status, can help protect the brain from the effects of the disease. In the study, which appears in Nature Neuroscience, Van Andel Institute scientists performed a genome-wide analysis of DNA methylation and hydroxymethylation at enhancers in neurons from Parkinson's disease patients and controls.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.